Purchases and Sales Made in Q3 2022 in Sonoma Pharmaceuticals, Inc. (SNOA)
This table provides information about the institutional ownership of Sonoma Pharmaceuticals, Inc. (SNOA) during Q3 2022. The information is specifically focused on institutions that hold shares of Sonoma Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
BUY
|
- |
4.84K+ 721.94% |
$10.5K - $210K
|
5.51K
$14.2K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
4.39K+ 839.01% |
$9.57K - $190K
|
4.91K
$12.7K
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 25, 2022
Q3 2022
|
Hbc Financial Services, Pllc
|
SELL
|
- |
-150- 42.86% |
$327 - $6.51K
|
200
$516
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-400- 0.53% |
$872 - $17.4K
|
75.4K
$194K
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-7.31K- 28.46% |
$15.9K - $317K
|
18.4K
$47.4K
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-7.38K- 99.41% |
$16.1K - $320K
|
44
$114
|